Import:3H Biomedizin: Unterschied zwischen den Versionen
en>Tomas e (Category tweak) |
Keine Bearbeitungszusammenfassung |
||
| Zeile 14: | Zeile 14: | ||
==History== | ==History== | ||
3H Biomedical was founded in 2004<ref>http://biotjanster.idg.se/guide/company.asp?id=571</ref> as a spring off from [[Uppsala University]]<ref>http://www.uu.se/node616</ref> | 3H Biomedical was founded in 2004<ref>http://biotjanster.idg.se/guide/company.asp?id=571</ref> as a spring off from [[Uppsala University]].<ref>http://www.uu.se/node616</ref> In the same year 3H Biomedical was awarded with the foundation of innovation of Handelsbanken Uppsala award. The award was presented for commercially interesting research in the field of DNA-based vaccines.<ref>Reference needed</ref> The company started out marketing and selling primary cells, and has since extended its portfolio with cell chips, [[RNA]], [[DNA]], recombinant proteins, [[blood plasma|blood serum and plasma]], [[Vector (molecular biology)|vectors]] for genetic modification and [[Assay|cell-based assays]].<ref>http://yellowpages.scanbalt.org/uppsala/Ups_search.php?company=12875</ref> | ||
==References== | ==References== | ||
Version vom 28. Juni 2009, 13:06 Uhr
Vorlage:Infobox Company 3H Biomedical is a biotechnology company based in Uppsala, Sweden, where it operates out of Uppsala Science Park. The company develops, produces and markets cell-based tools for life science, tissue engineering, drug discovery and cosmetics testing. 3H Biomedical also offers contract research services. The company’s research and development focus lays in the fields of cell immune therapy and adult stem cell therapy.[1]
History
3H Biomedical was founded in 2004[2] as a spring off from Uppsala University.[3] In the same year 3H Biomedical was awarded with the foundation of innovation of Handelsbanken Uppsala award. The award was presented for commercially interesting research in the field of DNA-based vaccines.[4] The company started out marketing and selling primary cells, and has since extended its portfolio with cell chips, RNA, DNA, recombinant proteins, blood serum and plasma, vectors for genetic modification and cell-based assays.[5]